On April 13, Wanfang Development (000638) recently released its 2020 annual report, and the company achieved operating income of 110,993,349.65 yuan during the reporting period, down 4.05% year-on-year; the net profit attributable to shareholders of listed companies was -17,055,247.54 yuan, from profit to loss over the same period last year.
Net cash flow from operating activities during the reporting period was -1,739,421.80 yuan, and net assets attributable to shareholders of the listed company as of the end of 2020 were 109,620,523.97 yuan.
During the reporting period, the total operating income was RMB110,993,349.65, a decrease of 4.05% over the same period last year. Among them, the sales and maintenance of ict and netease medical software and hardware, system integration and maintenance were 91,144,565.69 yuan, accounting for 82.12% of the operating income; the trade of Wanfang Maijie and Wanjing Fangqi grain and chemical products was 18,284,427.55 yuan, accounting for 16.47% of the operating income, and the consulting services of Wanfang Jiahui were 1,564,356.41 yuan, accounting for 1.41% of the operating income.
During the reporting period, the total operating cost was 80,174,833.71 yuan, an increase of 28.69% over the previous year. Among them, the sales and maintenance of ICT NetEase medical hardware and software, system integration and maintenance were 62,338,140.39 yuan, accounting for 77.75% of the operating cost; the trade of Wanfang Maijie and Wanjing Fangqi grain and chemical products was 17,406,693.32 yuan, accounting for 21.71% of the operating cost, and the consulting services of Wanfang Jiahui were 430,000.00 yuan, accounting for 0.54% of the operating cost.
During the reporting period, the amount of administrative expenses was RMB27,593,392.46, an increase of 23.1% over the previous year, mainly due to the expansion of the business of the subsidiary, ICT NetEase. The amount of sales expenses was 12,552,815.87 yuan, an increase of 15.90% over the previous year, mainly due to the increase in sales expenses of subsidiary Xintong NetEase.
Finance expense for the Period was $2,031,797.43, compared to $3,594,918.04 in the same period last year, down 43.48% year-on-year, and the exchange gain or loss decreased after the disposal of Wanfang Development (Hong Kong) Industrial Limited. Investment income for the Period was RMB4,989,307.92, compared to RMB11,445,524.44 in the same period last year, mainly due to the decline in the operating performance of Yixian Medical, a subsidiary of the Company.
According to the announcement, the remuneration of directors, supervisors and senior management during the reporting period totaled 1.9324 million yuan. The total pre-tax remuneration received by Chairman Zhang Hui from the company was 23,800 yuan, the total pre-tax remuneration received by General Manager and Director Zhang Hanhui from the company was 276,000 yuan, the total pre-tax remuneration received by Financial Director Dong Weiya from the company was 124,400 yuan, and the total pre-tax remuneration received by Guo Zibin, secretary of the board of directors and director, was 227,300 yuan.
The announcement discloses that the company plans not to pay cash dividends, not to send bonus shares, and not to use the provident fund to increase the share capital.
According to the data of The Shell Network, Wanfang Development is mainly engaged in software and information technology service business.
Source link: http://www.szse.cn/disclosure/listed/bulletinDetail/index.html?2e4c37a5-ed96-439b-a7b5-25be043b22fa
This article originated from the digging shell network